Cargando…
Perrone RD, Mouksassi M-S, Romero K, et al. Total kidney volume is a prognostic biomarker of renal function decline and progression to end-stage renal disease in patients with autosomal dominant polycystic kidney disease. Kidney Int Rep. 2017;2:442–450
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6035136/ https://www.ncbi.nlm.nih.gov/pubmed/29989052 http://dx.doi.org/10.1016/j.ekir.2018.05.006 |
Ejemplares similares
-
Erratum to “Perrone RD, Chapman AB, Oberdhan D, et al. The NOCTURNE Randomized Trial Comparing 2 Tolvaptan Formulations.” Kidney Int. Rep. 2020;5:801–812
Publicado: (2020) -
Renal disease progression in autosomal dominant polycystic kidney disease
por: Higashihara, Eiji, et al.
Publicado: (2012) -
Afshinnia F, Rajendiran TM, Karnovsky A, et al. Lipidomic Signature of Progression of Chronic Kidney Disease in the Chronic Renal Insufficiency Cohort. Kidney Int Rep. 2016;1:256–268
Publicado: (2017) -
Somatostatin in renal physiology and autosomal dominant polycystic kidney disease
por: Messchendorp, A Lianne, et al.
Publicado: (2019) -
Autosomal dominant polycystic kidney disease complicating renal ectopia and managed with renal transplantation
por: Connor, Andrew, et al.
Publicado: (2009)